Inventor
HUTT MEIKE
DE11 patents
⚠️ This page may combine multiple inventors who share the name “HUTT MEIKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMATICS BIOTECHNOLOGIES GMBH
8 patentsUS10618956B2Apr 14, 2020
Engineered T cell receptors and immune therapy using the same
IMMATICS BIOTECHNOLOGIES GMBH13 citations93
US10889645B2Jan 12, 2021
Engineered T cell receptors and immune therapy using the same
IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US11840577B2Dec 12, 2023
Antigen binding proteins specifically binding MAGE-A
IMMATICS BIOTECHNOLOGIES GMBH2 citations70
US11932689B2Mar 19, 2024
Engineered T cell receptors and immune therapy using the same
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12269881B2Apr 8, 2025
Antigen binding proteins specifically binding MAGE-A
IMMATICS BIOTECHNOLOGIES GMBH0 citations60
US12570760B2Mar 10, 2026
Antigen binding proteins specifically binding PRAME
IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US11859009B2Jan 2, 2024
Antigen binding proteins specifically binding PRAME
IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US12480958B2Nov 25, 2025
Method for the characterization of peptide:MHC binding polypeptides
IMMATICS BIOTECHNOLOGIES GMBH0 citations49
UNIV STUTTGART
3 patentsUS10428120B2Oct 1, 2019
Serum half-life extension using IgBD
UNIV STUTTGART19 citations93
US11008402B2May 18, 2021
Antigen binding protein against HER3
UNIV STUTTGART3 citations66
US10428149B2Oct 1, 2019
Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof
UNIV STUTTGART1 citations60